vs
Side-by-side financial comparison of SMITH & NEPHEW PLC (SNN) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | — | $1.9B |
| Q4 25 | — | $139.4M | ||
| Q3 25 | — | $230.9M | ||
| Q2 25 | — | $152.8M | ||
| Q1 25 | — | $182.0M | ||
| Q4 24 | — | $239.5M | ||
| Q3 24 | — | $249.1M | ||
| Q2 24 | — | $242.8M | ||
| Q1 24 | — | $172.4M |
| Q4 25 | — | 64.7% | ||
| Q3 25 | — | 72.1% | ||
| Q2 25 | — | 71.5% | ||
| Q1 25 | — | 71.2% | ||
| Q4 24 | — | 71.0% | ||
| Q3 24 | — | 70.5% | ||
| Q2 24 | — | 71.5% | ||
| Q1 24 | — | 72.9% |
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 14.4% | ||
| Q1 25 | — | 15.3% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | — | 18.1% | ||
| Q1 24 | — | 14.1% |
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | 7.4% | ||
| Q1 25 | — | 9.5% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | 9.1% |
| Q4 25 | — | $0.71 | ||
| Q3 25 | — | $1.16 | ||
| Q2 25 | — | $0.77 | ||
| Q1 25 | — | $0.91 | ||
| Q4 24 | — | $1.18 | ||
| Q3 24 | — | $1.23 | ||
| Q2 24 | — | $1.18 | ||
| Q1 24 | — | $0.84 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
